These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 6147392)

  • 21. Pharmacologic effects of L-dopa are not closely linked temporally to striatal dopamine concentration.
    Spencer SE; Wooten GF
    Neurology; 1984 Dec; 34(12):1609-11. PubMed ID: 6504335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Muscarinic antagonists in substantia nigra influence the decarboxylation of L-dopa in striatum.
    Izurieta-Sánchez P; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Jul; 399(2-3):151-60. PubMed ID: 10884514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic treatment with 1-dopa plus carbidopa in hemitransected rats: preferential effects at intact dopamine synapses leading to behavioural signs of dopamine receptor supersensitivity.
    Agnati LF; Fuxe K; Calza L; Zini I; Benefenati F; Farabegoli C; Goldstein M
    Acta Physiol Scand; 1983 May; 118(1):27-34. PubMed ID: 6137934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine.
    Blunt SB; Jenner P; Marsden CD
    Mov Disord; 1993 Apr; 8(2):129-33. PubMed ID: 8097279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration.
    Toffa S; Kunikowska GM; Zeng BY; Jenner P; Marsden CD
    J Neural Transm (Vienna); 1997; 104(1):67-75. PubMed ID: 9085194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manipulation of glutathione contents fails to alter dopaminergic nigrostriatal neurotoxicity of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Perry TL; Yong VW; Jones K; Wright JM
    Neurosci Lett; 1986 Oct; 70(2):261-5. PubMed ID: 3490637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endogenous neurotensin attenuates dopamine-dependent locomotion and stereotypy.
    Chartoff EH; Szczypka MS; Palmiter RD; Dorsa DM
    Brain Res; 2004 Oct; 1022(1-2):71-80. PubMed ID: 15353215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decarboxylation of exogenous L-DOPA in rat striatum after lesions of the dopaminergic nigrostriatal neurons: the role of striatal capillaries.
    Melamed E; Hefti F; Wurtman RJ
    Brain Res; 1980 Sep; 198(1):244-8. PubMed ID: 7407592
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
    Kozina EA; Kim AR; Kurina AY; Ugrumov MV
    Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levodopa induces long-lasting modification in the functional activity of the nigrostriatal pathway.
    Riverol M; Ordóñez C; Collantes M; DiCaudo C; Peñuelas I; Arbizu J; Marcilla I; Luquin MR
    Neurobiol Dis; 2014 Feb; 62():250-9. PubMed ID: 24076099
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergistic effect of alpha-dihydroergocryptine and L-dopa or dopamine on dopaminergic neurons in primary culture.
    Gille G; Radad K; Reichmann H; Rausch WD
    J Neural Transm (Vienna); 2006 Sep; 113(9):1107-18. PubMed ID: 16252065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. D-dopa and L-dopa similarly elevate brain dopamine and produce turning behavior in rats.
    Karoum F; Freed WJ; Chuang LW; Cannon-Spoor E; Wyatt RJ; Costa E
    Brain Res; 1988 Feb; 440(1):190-4. PubMed ID: 3129126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.
    Camp DM; Loeffler DA; LeWitt PA
    J Neurochem; 2000 Mar; 74(3):1229-40. PubMed ID: 10693956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Levodopa induction of Fos immunoreactivity in rat brain following partial and complete lesions of the substantia nigra.
    Cole DG; Growdon JH; DiFiglia M
    Exp Neurol; 1993 Apr; 120(2):223-32. PubMed ID: 8491280
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MK801 influences L-DOPA-induced dopamine release in intact and hemi-parkinson rats.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    Eur J Pharmacol; 2000 Nov; 407(3):281-91. PubMed ID: 11068024
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of L-dopa-induced circling in rats with nigral lesions by blockade of central dopa-decarboxylase: implications for mechanism of action of L-dopa in parkinsonism.
    Melamed E; Hefti F; Bitton V; Globus M
    Neurology; 1984 Dec; 34(12):1566-70. PubMed ID: 6504328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual effects of L-DOPA on nigral dopaminergic neurons.
    Guatteo E; Yee A; McKearney J; Cucchiaroni ML; Armogida M; Berretta N; Mercuri NB; Lipski J
    Exp Neurol; 2013 Sep; 247():582-94. PubMed ID: 23481547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic L-DOPA-pretreatment of rats: an electrophysiological and biochemical study in the basal ganglia.
    Jackson DM; Walters JR; Miller LP
    Brain Res; 1982 Nov; 250(2):271-82. PubMed ID: 6129029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].
    Ugrumov MV
    J Soc Biol; 2009; 203(1):75-85. PubMed ID: 19358813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.